Influenza Vaccination and Risk of Stroke in Older Adults
Drug Topics
SEPTEMBER 30, 2024
Researchers addressed the association between older individuals who received an influenza vaccine and their risk of stroke following vaccination.
Drug Topics
SEPTEMBER 30, 2024
Researchers addressed the association between older individuals who received an influenza vaccine and their risk of stroke following vaccination.
STAT
SEPTEMBER 30, 2024
A large outbreak of Marburg virus in Rwanda is drawing international concern about the possibility of spread beyond the country’s borders. The number of cases detected so far, 27 , already makes the outbreak one of the biggest involving Marburg on record. Nine of those individuals have died. There are currently no licensed vaccines to combat the disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 30, 2024
Sara T. Thomason discuses the impact of stigma on pharmacists who are dealing with substance use disorder, the importance of mental health care, and how schools support pharmacy students dealing with addiction.
STAT
SEPTEMBER 30, 2024
Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs even lost their bonuses. But the biggest names in health care still made $3.5 billion combined last year, compared with $4 billion in 2022. The average chief executive brought home $11 million, while the median was $4.1 million.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
SEPTEMBER 30, 2024
Left ventricular ejection fraction, brain natriuretic peptide, and heart failure-related hospitalizations were among the improved metrics.
Pharmacy Times
SEPTEMBER 30, 2024
MDL-101 is a proposed novel precision medicine that targets the LAMA1 gene, causing LAMA2 congenital muscular dystrophy type 1a.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
SEPTEMBER 30, 2024
The guidelines mark a shift in practice by recommending a multimodal approach to opioid prescribing practices.
Drug Topics
SEPTEMBER 30, 2024
Catch up on important pain management news from the month of September 2024.
STAT
SEPTEMBER 30, 2024
When I was a medical student in the 1980s, the school hired “pelvic instructors” who taught us how to do exams in a painless and respectful way. They even allowed us to perform practice examinations on them. But at the same time, senior doctors urged me to perform pelvic exams on anesthetized women about to get surgery — women who never gave consent.
Drug Topics
SEPTEMBER 30, 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 30, 2024
Prime Medicine, founded with gene-editing tech from the lab of star Harvard biochemist David Liu and backed by blue chip investors, made little secret of its ambition. It laid out plans to use its new gene-editing technology across 18 different diseases, listing conditions as disparate as ALS, congenital blindness, and muscular dystrophy.
Drug Topics
SEPTEMBER 30, 2024
Investigators suggested that the future cost-effectiveness of respiratory syncytial virus (RSV) vaccination could be improved through lower vaccine prices and longer-lasting protection.
Pharmacy Times
SEPTEMBER 30, 2024
Aaron Adkisson, PharmD, discusses the importance of considering factors such as age, gender, and cardiovascular comorbidities when monitoring and managing cardiotoxic risks in patients with cancer. also emphasizing patient education on recognizing early heart failure symptoms.
Drug Topics
SEPTEMBER 30, 2024
Research was presented at the Heart Failure Society of America 2024 Annual Meeting.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
SEPTEMBER 30, 2024
There was a detrimental relationship between COVID-19 caseload and mortality observed across multiple types of hospitals.
PharmaVoice
SEPTEMBER 30, 2024
In recent months, high-profile drug shortages have brought pharmaceutical manufacturing operations into the spotlight.
Pharmacy Times
SEPTEMBER 30, 2024
C. diff survivor and Peggy Lillis Foundation Board Member Maryann Webb discusses how her experience with the infection encouraged her to advocate for patients who are struggling to advocate for themselves.
Fierce Healthcare
SEPTEMBER 30, 2024
Food insecurity is a critical challenge facing seniors, and SCAN Health Plan is teaming up with Instacart to roll out a new grocery benefit as part of its 2025 Medicare Advantage plan lineup. | Food insecurity is a critical challenge facing seniors, and SCAN Health Plan is teaming up with Instacart to roll out a new grocery benefit as part of its 2025 Medicare Advantage plan lineup.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 30, 2024
DCVC Bio, a Silicon Valley area investment firm launched six years ago by a group of tech, bio, and agriculture investors, has raised a new $400 million fund, it told STAT exclusively. This is the third fund DCVC Bio has raised. It came in ahead of the original $350 million goal, according to executives. The announcement makes DCVC Bio one of a select number of biotech VCs to raise new pools of capital this year.
Fierce Healthcare
SEPTEMBER 30, 2024
As the calendar turns to October, the health insurance industry is gearing up for Medicare's annual enrollment period. | As the calendar turns to October, the health insurance industry is gearing up for Medicare's annual enrollment period.
STAT
SEPTEMBER 30, 2024
At last count, the Food and Drug Administration has authorized 950 medical devices that use artificial intelligence and machine learning. But far fewer have made a significant impact on patient care in the United States. For medical AI developers like James Zou, that’s a problem. The Stanford professor is invested in getting effective medical machine learning — including some of his own, FDA-cleared algorithms — adopted by health systems.
Pharmacy Times
SEPTEMBER 30, 2024
Alan Corley, pharmacy owner in Greenville, TN, reflects on the changes he's witnessed throughout his career and the most rewarding aspects of his profession.
STAT
SEPTEMBER 30, 2024
LONDON — Roche executives on Monday argued that their experimental obesity medications would prove to have advantages over their rivals’ products — and that the huge demand for effective weight loss drugs means there is room for another company in the field. “We wouldn’t have moved forward with these assets if we didn’t feel they were differentiated,” including in their molecular makeup and how they could be used in combination with other treatmen
Fierce Healthcare
SEPTEMBER 30, 2024
A key hedge fund investor for CVS Health will meet with the company's top brass today in a move that signals a potential activist approach going forward,
pharmaphorum
SEPTEMBER 30, 2024
Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy Nicole.
Fierce Healthcare
SEPTEMBER 30, 2024
'Good business and good health go hand in hand': Reducing inequities could add $2.
STAT
SEPTEMBER 30, 2024
Dear Reader, STAT is on fire! Not literally, of course.
pharmaphorum
SEPTEMBER 30, 2024
Genentech buys Regor's next-gen CDK inhibitors for $850M Jonah.
Pharmaceutical Commerce
SEPTEMBER 30, 2024
Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.
pharmaphorum
SEPTEMBER 30, 2024
Find out how AI can help prevent burnout and optimise pharmacist time in the pharmacy setting. Learn how technology can streamline processes and improve efficiency in this crucial healthcare profession.
Pharmaceutical Technology
SEPTEMBER 30, 2024
The first needle-free epinephrine nasal spray, Neffy by ARS Pharmaceuticals, represents a significant breakthrough in emergency treatment for type I allergic reactions.
The Checkup by Singlecare
SEPTEMBER 30, 2024
Ozempic (active ingredient semaglutide) is a GLP-1 receptor agonist that is FDA approved to manage Type 2 diabetes in adults in conjunction with a reduced-calorie diet and regular exercise. Like other medications in its class, such as Wegovy and Mounjaro , Ozempic mimics the actions of GLP-1, a hormone that controls appetite and stimulates insulin release.
Fierce Pharma
SEPTEMBER 30, 2024
After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound in 2025. | Ahead of the CPHI conference in Milan, the events group has teased new research signaling an expected rebound for the CDMO industry—and a rejection of the BIOSECURE Act.
Let's personalize your content